SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3pfq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DF7_A_MTXA501_2 (DIHYDROFOLATE REDUCTASE)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	3 / 3	TRP A 223 ARG A 252 THR A 214	None	0.85A	1df7A-3pfqA: undetectable	1df7A-3pfqA: 13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L2I_A_CCSA417_0 (ESTROGEN RECEPTOR)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	3 / 3	GLU A 511 LYS A 520 VAL A 522	None	0.92A	1l2iA-3pfqA: undetectable	1l2iA-3pfqA: 16.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OPJ_B_STIB4_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	4 / 6	LEU A 348 LYS A 371 VAL A 393 ARG A 465	ANP A 800 ( 4.4A) ANP A 800 (-3.3A) None TPO A 500 ( 2.9A)	1.09A	1opjB-3pfqA: 19.0	1opjB-3pfqA: 18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XF1_A_ACTA1107_0 (C5A PEPTIDASE)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	4 / 5	LEU A 474 GLY A 478 HIS A 479 ILE A 480	None	0.94A	1xf1A-3pfqA: 2.7	1xf1A-3pfqA: 22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	9 / 12	LEU A 348 VAL A 356 ALA A 369 VAL A 423 ASP A 466 LYS A 468 ASN A 471 MET A 473 ASP A 484	ANP A 800 ( 4.4A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-4.0A) None None ANP A 800 ( 4.5A) ANP A 800 ( 4.6A) ANP A 800 (-3.0A)	0.80A	2fumA-3pfqA: 24.5	2fumA-3pfqA: 18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_B_MIXB1539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	7 / 12	LEU A 348 GLY A 349 VAL A 356 ALA A 369 MET A 420 TYR A 422 VAL A 423	ANP A 800 ( 4.4A) ANP A 800 ( 4.3A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-4.8A) ANP A 800 (-4.2A) ANP A 800 (-4.0A)	0.77A	2fumB-3pfqA: 24.4	2fumB-3pfqA: 18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_B_MIXB1539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	10 / 12	LEU A 348 VAL A 356 ALA A 369 MET A 420 TYR A 422 VAL A 423 LYS A 468 ASN A 471 MET A 473 ASP A 484	ANP A 800 ( 4.4A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-4.8A) ANP A 800 (-4.2A) ANP A 800 (-4.0A) None ANP A 800 ( 4.5A) ANP A 800 ( 4.6A) ANP A 800 (-3.0A)	0.83A	2fumB-3pfqA: 24.4	2fumB-3pfqA: 18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	7 / 12	LEU A 348 GLY A 349 VAL A 356 ALA A 369 MET A 420 TYR A 422 VAL A 423	ANP A 800 ( 4.4A) ANP A 800 ( 4.3A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-4.8A) ANP A 800 (-4.2A) ANP A 800 (-4.0A)	0.81A	2fumC-3pfqA: 22.8	2fumC-3pfqA: 18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	8 / 12	LEU A 348 VAL A 356 ALA A 369 MET A 420 TYR A 422 VAL A 423 ASN A 471 MET A 473	ANP A 800 ( 4.4A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-4.8A) ANP A 800 (-4.2A) ANP A 800 (-4.0A) ANP A 800 ( 4.5A) ANP A 800 ( 4.6A)	0.88A	2fumC-3pfqA: 22.8	2fumC-3pfqA: 18.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IVU_A_ZD6A3015_0 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	7 / 12	LEU A 348 GLY A 349 VAL A 356 LYS A 371 GLU A 390 LEU A 394 TYR A 422	ANP A 800 ( 4.4A) ANP A 800 ( 4.3A) ANP A 800 ( 4.7A) ANP A 800 (-3.3A) None None ANP A 800 (-4.2A)	0.68A	2ivuA-3pfqA: 22.6	2ivuA-3pfqA: 19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OIP_E_MTXE621_1 (CHAIN A, CRYSTAL STRUCTURE OF DHFR)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	5 / 12	ALA A 443 LEU A 428 LEU A 530 ILE A 482 LEU A 454	None	1.10A	2oipE-3pfqA: undetectable	2oipE-3pfqA: 21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W1B_A_DXCA2034_0 (ACRIFLAVIN RESISTANCE PROTEIN B)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	3 / 3	PHE A 255 SER A 241 LEU A 259	None	0.72A	2w1bA-3pfqA: undetectable	2w1bA-3pfqA: 19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FUP_A_MI1A1_1 (TYROSINE-PROTEIN KINASE JAK2)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	8 / 12	LEU A 348 GLY A 349 GLY A 354 VAL A 356 ALA A 369 LYS A 371 MET A 420 TYR A 422	ANP A 800 ( 4.4A) ANP A 800 ( 4.3A) None ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-3.3A) ANP A 800 (-4.8A) ANP A 800 (-4.2A)	0.64A	3fupA-3pfqA: 22.0	3fupA-3pfqA: 17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IW1_A_ASDA1223_1 (CYTOCHROME P450 CYP125)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	5 / 12	ILE A 263 VAL A 271 VAL A 175 ILE A 162 VAL A 242	None	1.10A	3iw1A-3pfqA: undetectable	3iw1A-3pfqA: 19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXK_A_MI1A1125_1 (TYROSINE-PROTEIN KINASE JAK3)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	8 / 12	LEU A 348 GLY A 349 VAL A 356 ALA A 369 LYS A 371 MET A 420 TYR A 422 ALA A 483	ANP A 800 ( 4.4A) ANP A 800 ( 4.3A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-3.3A) ANP A 800 (-4.8A) ANP A 800 (-4.2A) ANP A 800 ( 3.8A)	0.83A	3lxkA-3pfqA: 22.0	3lxkA-3pfqA: 16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXN_A_MI1A1_1 (NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	7 / 12	LEU A 348 GLY A 349 VAL A 356 ALA A 369 LYS A 371 TYR A 422 VAL A 423	ANP A 800 ( 4.4A) ANP A 800 ( 4.3A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-3.3A) ANP A 800 (-4.2A) ANP A 800 (-4.0A)	0.70A	3lxnA-3pfqA: 22.3	3lxnA-3pfqA: 18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	7 / 12	VAL A 356 ALA A 369 LYS A 371 GLU A 390 VAL A 393 TYR A 422 ALA A 483	ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-3.3A) None None ANP A 800 (-4.2A) ANP A 800 ( 3.8A)	0.87A	3oezB-3pfqA: 15.2	3oezB-3pfqA: 17.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	7 / 12	VAL A 356 ALA A 369 GLU A 390 LEU A 394 TYR A 422 LEU A 457 ALA A 483	ANP A 800 ( 4.7A) ANP A 800 (-3.6A) None None ANP A 800 (-4.2A) None ANP A 800 ( 3.8A)	0.88A	3rgfA-3pfqA: 18.5	3rgfA-3pfqA: 20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	4 / 7	VAL A 356 ALA A 369 LEU A 373 MET A 420	ANP A 800 ( 4.7A) ANP A 800 (-3.6A) None ANP A 800 (-4.8A)	0.76A	4l9iA-3pfqA: 22.8	4l9iA-3pfqA: 27.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PEV_C_ADNC501_1 (MEMBRANE LIPOPROTEIN FAMILY PROTEIN)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	5 / 12	SER A 260 PHE A 261 ASN A 287 LEU A 173 GLY A 262	None	1.50A	4pevC-3pfqA: undetectable	4pevC-3pfqA: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	6 / 12	ALA A 369 GLU A 390 THR A 404 TYR A 422 ALA A 483 ASP A 484	ANP A 800 (-3.6A) None ANP A 800 ( 3.8A) ANP A 800 (-4.2A) ANP A 800 ( 3.8A) ANP A 800 (-3.0A)	0.59A	4qmnA-3pfqA: 28.5	4qmnA-3pfqA: 17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	7 / 12	ALA A 369 LYS A 371 GLU A 390 THR A 404 MET A 420 TYR A 422 ASP A 484	ANP A 800 (-3.6A) ANP A 800 (-3.3A) None ANP A 800 ( 3.8A) ANP A 800 (-4.8A) ANP A 800 (-4.2A) ANP A 800 (-3.0A)	1.06A	4qmnA-3pfqA: 28.5	4qmnA-3pfqA: 17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMZ_A_B49A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	6 / 12	GLY A 349 VAL A 356 ALA A 369 THR A 404 MET A 420 TYR A 422	ANP A 800 ( 4.3A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 ( 3.8A) ANP A 800 (-4.8A) ANP A 800 (-4.2A)	0.66A	4qmzA-3pfqA: 21.4	4qmzA-3pfqA: 17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QRC_A_0LIA802_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	5 / 12	ALA A 369 GLU A 390 LEU A 457 ARG A 465 ALA A 483	ANP A 800 (-3.6A) None None TPO A 500 ( 2.9A) ANP A 800 ( 3.8A)	1.14A	4qrcA-3pfqA: 16.5	4qrcA-3pfqA: 19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCK_A_SAMA2409_1 (RNA-DIRECTED RNA POLYMERASE L)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	3 / 3	SER A 552 ASP A 523 ASP A 506	None	0.82A	4uckA-3pfqA: undetectable	4uckA-3pfqA: 21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V01_A_0LIA1776_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	6 / 9	LEU A 348 VAL A 356 LYS A 371 TYR A 422 ARG A 465 ILE A 482	ANP A 800 ( 4.4A) ANP A 800 ( 4.7A) ANP A 800 (-3.3A) ANP A 800 (-4.2A) TPO A 500 ( 2.9A) None	0.99A	4v01A-3pfqA: 19.0	4v01A-3pfqA: 19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	6 / 10	LEU A 348 VAL A 356 LYS A 371 TYR A 422 ARG A 465 ILE A 482	ANP A 800 ( 4.4A) ANP A 800 ( 4.7A) ANP A 800 (-3.3A) ANP A 800 (-4.2A) TPO A 500 ( 2.9A) None	1.11A	4v04B-3pfqA: 19.6	4v04B-3pfqA: 19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WCX_C_SAMC503_1 (BIOTIN AND THIAMIN SYNTHESIS ASSOCIATED)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	4 / 6	CYH A 488 LEU A 406 GLU A 390 TYR A 464	None	1.38A	4wcxC-3pfqA: undetectable	4wcxC-3pfqA: 20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HPU_A_IPHA101_0 (INSULIN, CHAIN A INSULIN, CHAIN B)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	4 / 4	CYH A 572 LEU A 535 LEU A 531 ALA A 443	None	1.09A	5hpuA-3pfqA: undetectable 5hpuB-3pfqA: undetectable	5hpuA-3pfqA: 2.88 5hpuB-3pfqA: 4.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	5 / 7	GLY A 349 GLY A 351 SER A 352 VAL A 356 LYS A 371	ANP A 800 ( 4.3A) None None ANP A 800 ( 4.7A) ANP A 800 (-3.3A)	1.26A	5j5xA-3pfqA: 29.6	5j5xA-3pfqA: 24.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	5 / 7	GLY A 349 SER A 352 VAL A 356 LYS A 371 ASP A 484	ANP A 800 ( 4.3A) None ANP A 800 ( 4.7A) ANP A 800 (-3.3A) ANP A 800 (-3.0A)	0.94A	5j5xA-3pfqA: 29.6	5j5xA-3pfqA: 24.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LSU_A_SAMA1304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD2)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	5 / 12	HIS A 107 HIS A 140 THR A 113 CYH A 115 LEU A 122	None ZN A 751 (-3.1A) None ZN A 751 (-2.7A) None	1.10A	5lsuA-3pfqA: undetectable	5lsuA-3pfqA: 16.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N3H_A_NCAA401_0 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	6 / 10	LEU A 348 VAL A 356 ALA A 369 MET A 420 TYR A 422 VAL A 423	ANP A 800 ( 4.4A) ANP A 800 ( 4.7A) ANP A 800 (-3.6A) ANP A 800 (-4.8A) ANP A 800 (-4.2A) ANP A 800 (-4.0A)	0.49A	5n3hA-3pfqA: 37.1	5n3hA-3pfqA: 23.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AG0_C_ACRC607_0 (ALPHA-AMYLASE)	3pfq	PROTEIN KINASE C BETA TYPE (Rattus norvegicus)	4 / 6	ASP A 523 GLY A 587 PRO A 588 GLY A 590	None	0.74A	6ag0C-3pfqA: undetectable	6ag0C-3pfqA: 6.82

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DF7_A_MTXA501_2","DIHYDROFOLATE REDUCTASE","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",3,"TRP A 223;ARG A 252;THR A 214","None","0.85A","1df7A-3pfqA:undetectable","1df7A-3pfqA:13.22"],["1L2I_A_CCSA417_0","ESTROGEN RECEPTOR","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",3,"GLU A 511;LYS A 520;VAL A 522","None","0.92A","1l2iA-3pfqA:undetectable","1l2iA-3pfqA:16.03"],["1OPJ_B_STIB4_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",4,"LEU A 348;LYS A 371;VAL A 393;ARG A 465","ANP A 800 ( 4.4A);ANP A 800 (-3.3A);None;TPO A 500 ( 2.9A)","1.09A","1opjB-3pfqA:19.0","1opjB-3pfqA:18.21"],["1XF1_A_ACTA1107_0","C5A PEPTIDASE","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",4,"LEU A 474;GLY A 478;HIS A 479;ILE A 480","None","0.94A","1xf1A-3pfqA:2.7","1xf1A-3pfqA:22.12"],["2FUM_A_MIXA539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",9,"LEU A 348;VAL A 356;ALA A 369;VAL A 423;ASP A 466;LYS A 468;ASN A 471;MET A 473;ASP A 484","ANP A 800 ( 4.4A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-4.0A);None;None;ANP A 800 ( 4.5A);ANP A 800 ( 4.6A);ANP A 800 (-3.0A)","0.80A","2fumA-3pfqA:24.5","2fumA-3pfqA:18.09"],["2FUM_B_MIXB1539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",7,"LEU A 348;GLY A 349;VAL A 356;ALA A 369;MET A 420;TYR A 422;VAL A 423","ANP A 800 ( 4.4A);ANP A 800 ( 4.3A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-4.8A);ANP A 800 (-4.2A);ANP A 800 (-4.0A)","0.77A","2fumB-3pfqA:24.4","2fumB-3pfqA:18.09"],["2FUM_B_MIXB1539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",10,"LEU A 348;VAL A 356;ALA A 369;MET A 420;TYR A 422;VAL A 423;LYS A 468;ASN A 471;MET A 473;ASP A 484","ANP A 800 ( 4.4A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-4.8A);ANP A 800 (-4.2A);ANP A 800 (-4.0A);None;ANP A 800 ( 4.5A);ANP A 800 ( 4.6A);ANP A 800 (-3.0A)","0.83A","2fumB-3pfqA:24.4","2fumB-3pfqA:18.09"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",7,"LEU A 348;GLY A 349;VAL A 356;ALA A 369;MET A 420;TYR A 422;VAL A 423","ANP A 800 ( 4.4A);ANP A 800 ( 4.3A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-4.8A);ANP A 800 (-4.2A);ANP A 800 (-4.0A)","0.81A","2fumC-3pfqA:22.8","2fumC-3pfqA:18.09"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",8,"LEU A 348;VAL A 356;ALA A 369;MET A 420;TYR A 422;VAL A 423;ASN A 471;MET A 473","ANP A 800 ( 4.4A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-4.8A);ANP A 800 (-4.2A);ANP A 800 (-4.0A);ANP A 800 ( 4.5A);ANP A 800 ( 4.6A)","0.88A","2fumC-3pfqA:22.8","2fumC-3pfqA:18.09"],["2IVU_A_ZD6A3015_0","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",7,"LEU A 348;GLY A 349;VAL A 356;LYS A 371;GLU A 390;LEU A 394;TYR A 422","ANP A 800 ( 4.4A);ANP A 800 ( 4.3A);ANP A 800 ( 4.7A);ANP A 800 (-3.3A);None;None;ANP A 800 (-4.2A)","0.68A","2ivuA-3pfqA:22.6","2ivuA-3pfqA:19.03"],["2OIP_E_MTXE621_1","CHAIN A, CRYSTAL STRUCTURE OF DHFR","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",5,"ALA A 443;LEU A 428;LEU A 530;ILE A 482;LEU A 454","None","1.10A","2oipE-3pfqA:undetectable","2oipE-3pfqA:21.47"],["2W1B_A_DXCA2034_0","ACRIFLAVIN RESISTANCE PROTEIN B","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",3,"PHE A 255;SER A 241;LEU A 259","None","0.72A","2w1bA-3pfqA:undetectable","2w1bA-3pfqA:19.73"],["3FUP_A_MI1A1_1","TYROSINE-PROTEIN KINASE JAK2","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",8,"LEU A 348;GLY A 349;GLY A 354;VAL A 356;ALA A 369;LYS A 371;MET A 420;TYR A 422","ANP A 800 ( 4.4A);ANP A 800 ( 4.3A);None;ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-3.3A);ANP A 800 (-4.8A);ANP A 800 (-4.2A)","0.64A","3fupA-3pfqA:22.0","3fupA-3pfqA:17.07"],["3IW1_A_ASDA1223_1","CYTOCHROME P450 CYP125","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",5,"ILE A 263;VAL A 271;VAL A 175;ILE A 162;VAL A 242","None","1.10A","3iw1A-3pfqA:undetectable","3iw1A-3pfqA:19.85"],["3LXK_A_MI1A1125_1","TYROSINE-PROTEIN KINASE JAK3","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",8,"LEU A 348;GLY A 349;VAL A 356;ALA A 369;LYS A 371;MET A 420;TYR A 422;ALA A 483","ANP A 800 ( 4.4A);ANP A 800 ( 4.3A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-3.3A);ANP A 800 (-4.8A);ANP A 800 (-4.2A);ANP A 800 ( 3.8A)","0.83A","3lxkA-3pfqA:22.0","3lxkA-3pfqA:16.26"],["3LXN_A_MI1A1_1","NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",7,"LEU A 348;GLY A 349;VAL A 356;ALA A 369;LYS A 371;TYR A 422;VAL A 423","ANP A 800 ( 4.4A);ANP A 800 ( 4.3A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-3.3A);ANP A 800 (-4.2A);ANP A 800 (-4.0A)","0.70A","3lxnA-3pfqA:22.3","3lxnA-3pfqA:18.62"],["3OEZ_B_STIB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",7,"VAL A 356;ALA A 369;LYS A 371;GLU A 390;VAL A 393;TYR A 422;ALA A 483","ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-3.3A);None;None;ANP A 800 (-4.2A);ANP A 800 ( 3.8A)","0.87A","3oezB-3pfqA:15.2","3oezB-3pfqA:17.26"],["3RGF_A_BAXA465_1","CYCLIN-DEPENDENT KINASE 8","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",7,"VAL A 356;ALA A 369;GLU A 390;LEU A 394;TYR A 422;LEU A 457;ALA A 483","ANP A 800 ( 4.7A);ANP A 800 (-3.6A);None;None;ANP A 800 (-4.2A);None;ANP A 800 ( 3.8A)","0.88A","3rgfA-3pfqA:18.5","3rgfA-3pfqA:20.62"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",4,"VAL A 356;ALA A 369;LEU A 373;MET A 420","ANP A 800 ( 4.7A);ANP A 800 (-3.6A);None;ANP A 800 (-4.8A)","0.76A","4l9iA-3pfqA:22.8","4l9iA-3pfqA:27.57"],["4PEV_C_ADNC501_1","MEMBRANE LIPOPROTEIN FAMILY PROTEIN","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",5,"SER A 260;PHE A 261;ASN A 287;LEU A 173;GLY A 262","None","1.50A","4pevC-3pfqA:undetectable","4pevC-3pfqA:22.17"],["4QMN_A_DB8A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",6,"ALA A 369;GLU A 390;THR A 404;TYR A 422;ALA A 483;ASP A 484","ANP A 800 (-3.6A);None;ANP A 800 ( 3.8A);ANP A 800 (-4.2A);ANP A 800 ( 3.8A);ANP A 800 (-3.0A)","0.59A","4qmnA-3pfqA:28.5","4qmnA-3pfqA:17.80"],["4QMN_A_DB8A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",7,"ALA A 369;LYS A 371;GLU A 390;THR A 404;MET A 420;TYR A 422;ASP A 484","ANP A 800 (-3.6A);ANP A 800 (-3.3A);None;ANP A 800 ( 3.8A);ANP A 800 (-4.8A);ANP A 800 (-4.2A);ANP A 800 (-3.0A)","1.06A","4qmnA-3pfqA:28.5","4qmnA-3pfqA:17.80"],["4QMZ_A_B49A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",6,"GLY A 349;VAL A 356;ALA A 369;THR A 404;MET A 420;TYR A 422","ANP A 800 ( 4.3A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 ( 3.8A);ANP A 800 (-4.8A);ANP A 800 (-4.2A)","0.66A","4qmzA-3pfqA:21.4","4qmzA-3pfqA:17.80"],["4QRC_A_0LIA802_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",5,"ALA A 369;GLU A 390;LEU A 457;ARG A 465;ALA A 483","ANP A 800 (-3.6A);None;None;TPO A 500 ( 2.9A);ANP A 800 ( 3.8A)","1.14A","4qrcA-3pfqA:16.5","4qrcA-3pfqA:19.50"],["4UCK_A_SAMA2409_1","RNA-DIRECTED RNA POLYMERASE L","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",3,"SER A 552;ASP A 523;ASP A 506","None","0.82A","4uckA-3pfqA:undetectable","4uckA-3pfqA:21.19"],["4V01_A_0LIA1776_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",6,"LEU A 348;VAL A 356;LYS A 371;TYR A 422;ARG A 465;ILE A 482","ANP A 800 ( 4.4A);ANP A 800 ( 4.7A);ANP A 800 (-3.3A);ANP A 800 (-4.2A);TPO A 500 ( 2.9A);None","0.99A","4v01A-3pfqA:19.0","4v01A-3pfqA:19.32"],["4V04_B_0LIB1771_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",6,"LEU A 348;VAL A 356;LYS A 371;TYR A 422;ARG A 465;ILE A 482","ANP A 800 ( 4.4A);ANP A 800 ( 4.7A);ANP A 800 (-3.3A);ANP A 800 (-4.2A);TPO A 500 ( 2.9A);None","1.11A","4v04B-3pfqA:19.6","4v04B-3pfqA:19.32"],["4WCX_C_SAMC503_1","BIOTIN AND THIAMIN SYNTHESIS ASSOCIATED","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",4,"CYH A 488;LEU A 406;GLU A 390;TYR A 464","None","1.38A","4wcxC-3pfqA:undetectable","4wcxC-3pfqA:20.44"],["5HPU_A_IPHA101_0","INSULIN, CHAIN A;INSULIN, CHAIN B","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",4,"CYH A 572;LEU A 535;LEU A 531;ALA A 443","None","1.09A","5hpuA-3pfqA:undetectable;5hpuB-3pfqA:undetectable","5hpuA-3pfqA:2.88;5hpuB-3pfqA:4.15"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",5,"GLY A 349;GLY A 351;SER A 352;VAL A 356;LYS A 371","ANP A 800 ( 4.3A);None;None;ANP A 800 ( 4.7A);ANP A 800 (-3.3A)","1.26A","5j5xA-3pfqA:29.6","5j5xA-3pfqA:24.29"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",5,"GLY A 349;SER A 352;VAL A 356;LYS A 371;ASP A 484","ANP A 800 ( 4.3A);None;ANP A 800 ( 4.7A);ANP A 800 (-3.3A);ANP A 800 (-3.0A)","0.94A","5j5xA-3pfqA:29.6","5j5xA-3pfqA:24.29"],["5LSU_A_SAMA1304_0","HISTONE-LYSINE N-METHYLTRANSFERASE NSD2","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",5,"HIS A 107;HIS A 140;THR A 113;CYH A 115;LEU A 122","None; ZN A 751 (-3.1A);None; ZN A 751 (-2.7A);None","1.10A","5lsuA-3pfqA:undetectable","5lsuA-3pfqA:16.27"],["5N3H_A_NCAA401_0","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",6,"LEU A 348;VAL A 356;ALA A 369;MET A 420;TYR A 422;VAL A 423","ANP A 800 ( 4.4A);ANP A 800 ( 4.7A);ANP A 800 (-3.6A);ANP A 800 (-4.8A);ANP A 800 (-4.2A);ANP A 800 (-4.0A)","0.49A","5n3hA-3pfqA:37.1","5n3hA-3pfqA:23.80"],["6AG0_C_ACRC607_0","ALPHA-AMYLASE","3pfq","PROTEIN KINASE C BETA TYPE","Rattus norvegicus",4,"ASP A 523;GLY A 587;PRO A 588;GLY A 590","None","0.74A","6ag0C-3pfqA:undetectable","6ag0C-3pfqA:6.82"]]